Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Roivant Sciences Ltd (NASDAQ: ROIV) closed the day trading at $10.74 down -2.27% from the previous closing price of $10.99. In other words, the price has decreased by -$2.27 from its previous closing price. On the day, 5.12 million shares were traded. ROIV stock price reached its highest trading level at $10.95 during the session, while it also had its lowest trading level at $10.72.
Ratios:
For a better understanding of ROIV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 33.47 and its Current Ratio is at 33.47. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On January 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $14.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 20 ’25 when Venker Eric sold 100,000 shares for $11.45 per share. The transaction valued at 1,145,000 led to the insider holds 1,462,223 shares of the business.
Ramaswamy Vivek sold 577,007 shares of ROIV for $6,612,500 on Jun 20 ’25. The 10% Owner now owns 37,284,108 shares after completing the transaction at $11.46 per share. On Jun 18 ’25, another insider, Ramaswamy Vivek, who serves as the 10% Owner of the company, sold 565,266 shares for $11.45 each. As a result, the insider received 6,472,296 and left with 37,861,115 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 7301116416 and an Enterprise Value of 3374286336. For the stock, the TTM Price-to-Sale (P/S) ratio is 95.83 while its Price-to-Book (P/B) ratio in mrq is 1.59. Its current Enterprise Value per Revenue stands at 116.142 whereas that against EBITDA is -3.146.
Stock Price History:
The Beta on a monthly basis for ROIV is 1.15, which has changed by -0.008310258 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, ROIV has reached a high of $13.06, while it has fallen to a 52-week low of $8.73. The 50-Day Moving Average of the stock is -3.57%, while the 200-Day Moving Average is calculated to be -4.07%.
Shares Statistics:
Over the past 3-months, ROIV traded about 6.52M shares per day on average, while over the past 10 days, ROIV traded about 7717600 shares per day. A total of 695.94M shares are outstanding, with a floating share count of 401.31M. Insiders hold about 40.97% of the company’s shares, while institutions hold 65.73% stake in the company. Shares short for ROIV as of 1749772800 were 45062132 with a Short Ratio of 6.92, compared to 1747267200 on 49232094. Therefore, it implies a Short% of Shares Outstanding of 45062132 and a Short% of Float of 9.0500005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
